[1]靳艳玲,刘国彦,莫善列,等.海洋中药蛎昆一号制剂对5-Fu化疗后所致动物骨髓抑制的功效研究[J].医学信息,2018,31(21):51-55.[doi:10.3969/j.issn.1006-1959.2018.21.015]
　JIN Yan-ling,LIU Guo-yan,MO Shan-lie,et al.Efficacy of Marine Chinese Medicine Likun No.1 Preparation on Animal Bone Marrow Suppression Induced by 5-Fu Chemotherapy[J].Journal of Medical Information,2018,31(21):51-55.[doi:10.3969/j.issn.1006-1959.2018.21.015]
点击复制

海洋中药蛎昆一号制剂对5-Fu化疗后所致动物骨髓抑制的功效研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年21期
页码:
51-55
栏目:
论著
出版日期:
2018-11-01

文章信息/Info

Title:
Efficacy of Marine Chinese Medicine Likun No.1 Preparation on Animal Bone Marrow Suppression Induced by 5-Fu Chemotherapy
文章编号:
1006-1959（2018）21-0051-05
作者:
靳艳玲1; 刘国彦2; 莫善列3; 叶 兰4; 张宇海5c
1.贵州医科大学基础医学院，贵州 贵阳 550025；2.厦门大学药学院/厦门大学附属中山医院，福建 厦门 361101；3.厦门大学药学院-华言科技肿瘤预防与康复研究中心，福建 厦门 361101；4.贵州医科大学基础医学院，贵州 贵阳 550025；5.厦门大学附属中山医院，福建 厦门 361101
Author(s):
JIN Yan-ling1; LIU Guo-yan2; MO Shan-lie3; YE Lan4; ZHANG Yu-hai5
1.School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550025,Guizhou,China;2.School of Pharmacy,Xiamen University/Zhongshan Hospital,Xiamen University,Xiamen 361101, Fujian,China;3.Institute of Pharmacy,Xiamen University-Huayin Science and
关键词:
蛎昆一号制剂; 5-氟尿嘧啶; 骨髓抑制; 血常规
Keywords:
Li kun No.1 preparation; 5-fluorouracil; Bone marrow suppression; Blood routine
分类号:
R285.5
DOI:
10.3969/j.issn.1006-1959.2018.21.015
文献标志码:
A
摘要:
目的 研究蛎昆一号制剂对5-氟尿嘧啶（5-Fu）致小鼠骨髓抑制外周血中白细胞、血小板、淋巴细胞、单核细胞计数的影响。方法 纯系雄性BALB/c种小鼠60只，随机分为对照组、5-Fu、5-Fu联用重组人粒细胞集落刺激因子（rhG-CSF）、蛎昆一号制剂低、中、高剂量6个组。经腹腔注射肿瘤化疗药5-Fu建立小鼠骨髓抑制模型，对照组注射等量生理盐水；注射后第1天上午使用不同剂量的蛎昆一号制剂灌胃，对照组等量生理盐水灌胃；给药7 d后上午取眼球血进行血常规分析。结果 小鼠在注射5-Fu造模后，外周血白细胞、血小板、淋巴细胞与对照组相比均有明显降低（P＜0.05），单核细胞比率与对照组相比明显升高（P＜0.05）；不同剂量的蛎昆一号制剂及阳性对照（rhG-CSF）均有效地升高小鼠外周血白细胞、血小板、淋巴细胞数值，且单核细胞比率也较模型组明显降低，但以蛎昆一号制剂中剂量组的效果最为明显，复方制剂高剂量组次之。结论 蛎昆一号制剂能够明显改善5-Fu化疗药物所引起的小鼠骨髓抑制现象，增加骨髓抑制小鼠外周血白细胞、血小板、淋巴细胞数目；降低外周血中单核细胞比率，表明蛎昆一号制剂能够有效的恢复骨髓抑制小鼠造血系统，提高造血活性。
Abstract:
Objective To study the effects of Likun No. 1 preparation on the counts of leukocytes, platelets, lymphocytes and monocytes in peripheral blood of mice induced by 5-fluorouracil (5-Fu). Methods 60 male BALB/c mice were randomly divided into control group, 5-Fu, 5-Fu combined with recombinant human granulocyte colony-stimulating factor (rhG-CSF),Likun No. 1 preparation has 6 groups of low, medium and high doses. The mouse bone marrow suppression model was established by intraperitoneal injection of the tumor chemotherapeutic drug 5-Fu. The control group was injected with the same amount of normal saline. On the first day after the injection, different doses of the Likun No. 1 preparation were administered by the stomach, and the control group was given the same amount of normal saline. After 7 d of administration, eyeballs were taken for routine blood analysis. Results After injection of 5-Fu, the peripheral blood leukocytes, platelets and lymphocytes were significantly lower than the control group (P<0.05), and the monocyte ratio was significantly higher than that of the control group (P<0.05). Different doses of Likun No. 1 preparation and positive control (rhG-CSF) effectively increased the peripheral blood leukocyte, platelet and lymphocyte values in mice, and the monocyte ratio was also significantly lower than that of the model group. The effect of the medium dose group of Likun No.1 preparation was the most obvious, followed by the high dose group of the compound preparation. Conclusion Likun No.1 preparation can significantly improve the bone marrow suppression induced by 5-Fu chemotherapy drugs, increase the number of peripheral blood leukocytes, platelets and lymphocytes in mice, and decrease the percentage of monocytes in peripheral blood. Likun No. 1 preparation can effectively restore the hematopoietic system of myelosuppressive mice and increase hematopoietic activity.

参考文献/References:

[1]Brenet F,Kermani P,Spektor R,et al.TGF-β restores hematopoietic homeostasis after myelosuppressive chemotherapy[J].J Exp Med,2013,210(3):623-639. [2]杨佩颖,李想,贾英杰.补益类中药治疗化疗后骨髓抑制的实验机制研究[J].时珍国医国药,2014,25(6):1456-1458. [3]中国实验动物学会.实验动物环境及设施：GB 14925-2001[S].北京:中国标准出版社,2002:26. [4]中华人民共和国卫生部.SN/T 4206-2015 出口植物源食品中粗多糖的测定[S].北京:中国出版社,2015. [5]张文清,左萍萍,徐辰,等.海带中岩藻多糖的分离纯化与结构分析[J].食品科学,2012,33(1):68-71. [6]Kopp HG,Avecilla ST,Hooper AT,et al.Tie2 activation contributes to hemangiogenic regeneration after myelosuppression[J].Blood,2005,106(2):505-513. [7]卢俊钦,孙文立,毛文伟.骨髓抑制-再生小鼠模型的建立及组织学改变的动态观察[J].上海交通大学学报(医学版),2010,30(7):758-762. [8]陈奇.中药药理研究方法学[M].北京:人民卫生出版社,2011. [9]沈倍奋,杨子义,许锦良,等.重组人粒细胞巨噬细胞集落刺激因子的研究[J].中华医学杂志,1996,76(9):654-657. [10]贾英杰,于健春,杨佩颖,等.中医药防治化疗致骨髓抑制的临床研究概况[J].辽宁中医杂志,2014,41(10):2253-2255. [11]栗敏,马洪宇,沈继朵,等.复方阿胶浆对H22肝癌荷瘤小鼠5-FU化疗的增效减毒作用[J].中国实验方剂学杂志,2012,18(20):216-219.

相似文献/References:

[1]王绥能,梁贤文,孙 光,等.伊立替康新辅助化疗在进展期胃癌的临床意义[J].医学信息,2018,31(24):164.[doi:10.3969/j.issn.1006-1959.2018.24.050]
　WANG Sui-neng,LIANG Xian-wen,SUN Guang,et al.Clinical Significance of Irinotecan Neoadjuvant Chemotherapy in Advanced Gastric Carcinoma[J].Journal of Medical Information,2018,31(21):164.[doi:10.3969/j.issn.1006-1959.2018.24.050]

更新日期/Last Update: 2018-11-20